Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SCLX vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SCLX
Scilex Holding Company

Drug Manufacturers - General

HealthcareNASDAQ • US
Market Cap$56M
5Y Perf.-97.7%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-71.0%

SCLX vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SCLX logoSCLX
PRGO logoPRGO
IndustryDrug Manufacturers - GeneralDrug Manufacturers - Specialty & Generic
Market Cap$56M$1.61B
Revenue (TTM)$40M$4.18B
Net Income (TTM)$-376M$-1.82B
Gross Margin68.6%34.2%
Operating Margin-6.5%-4.1%
Forward P/E2.6x5.6x
Total Debt$38M$3.97B
Cash & Equiv.$3M$532M

SCLX vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SCLX
PRGO
StockMar 21May 26Return
Scilex Holding Comp… (SCLX)1002.3-97.7%
Perrigo Company plc (PRGO)10029.0-71.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: SCLX vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PRGO leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Scilex Holding Company is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
SCLX
Scilex Holding Company
The Growth Play

SCLX is the clearest fit if your priority is growth exposure.

  • Rev growth 21.1%, EPS growth 56.7%, 3Y rev CAGR 21.8%
  • 21.1% revenue growth vs PRGO's -2.8%
  • Lower P/E (2.6x vs 5.6x)
Best for: growth exposure
PRGO
Perrigo Company plc
The Income Pick

PRGO carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • -77.7% 10Y total return vs SCLX's -97.7%
  • Lower volatility, beta 1.18, current ratio 2.76x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthSCLX logoSCLX21.1% revenue growth vs PRGO's -2.8%
ValueSCLX logoSCLXLower P/E (2.6x vs 5.6x)
Quality / MarginsPRGO logoPRGO-43.5% margin vs SCLX's -9.3%
Stability / SafetyPRGO logoPRGOBeta 1.18 vs SCLX's 2.50
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other pay no meaningful dividend
Momentum (1Y)SCLX logoSCLX+74.4% vs PRGO's -51.2%
Efficiency (ROA)PRGO logoPRGO-19.8% ROA vs SCLX's -136.2%

SCLX vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SCLXScilex Holding Company

Segment breakdown not available.

PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

SCLX vs PRGO — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPRGOLAGGINGSCLX

Income & Cash Flow (Last 12 Months)

Evenly matched — SCLX and PRGO each lead in 3 of 6 comparable metrics.

PRGO is the larger business by revenue, generating $4.2B annually — 103.5x SCLX's $40M. Profitability is closely matched — net margins range from -43.5% (PRGO) to -9.3% (SCLX). On growth, PRGO holds the edge at -7.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSCLX logoSCLXScilex Holding Co…PRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$40M$4.2B
EBITDAEarnings before interest/tax-$259M$58M
Net IncomeAfter-tax profit-$376M-$1.8B
Free Cash FlowCash after capex$24M$108M
Gross MarginGross profit ÷ Revenue+68.6%+34.2%
Operating MarginEBIT ÷ Revenue-6.5%-4.1%
Net MarginNet income ÷ Revenue-9.3%-43.5%
FCF MarginFCF ÷ Revenue+59.0%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year-26.8%-7.2%
EPS Growth (YoY)Latest quarter vs prior year-17.3%-56.4%
Evenly matched — SCLX and PRGO each lead in 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SCLX and PRGO each lead in 2 of 4 comparable metrics.
MetricSCLX logoSCLXScilex Holding Co…PRGO logoPRGOPerrigo Company p…
Market CapShares × price$56M$1.6B
Enterprise ValueMkt cap + debt − cash$91M$5.1B
Trailing P/EPrice ÷ TTM EPS-0.41x-1.14x
Forward P/EPrice ÷ next-FY EPS est.2.59x5.56x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple7.42x
Price / SalesMarket cap ÷ Revenue0.99x0.38x
Price / BookPrice ÷ Book value/share0.55x
Price / FCFMarket cap ÷ FCF2.89x11.12x
Evenly matched — SCLX and PRGO each lead in 2 of 4 comparable metrics.

Profitability & Efficiency

SCLX leads this category, winning 3 of 5 comparable metrics.

On the Piotroski fundamental quality scale (0–9), SCLX scores 6/9 vs PRGO's 4/9, reflecting solid financial health.

MetricSCLX logoSCLXScilex Holding Co…PRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity-50.7%
ROA (TTM)Return on assets-136.2%-19.8%
ROICReturn on invested capital+3.7%
ROCEReturn on capital employed+4.3%
Piotroski ScoreFundamental quality 0–964
Debt / EquityFinancial leverage1.35x
Net DebtTotal debt minus cash$35M$3.4B
Cash & Equiv.Liquid assets$3M$532M
Total DebtShort + long-term debt$38M$4.0B
Interest CoverageEBIT ÷ Interest expense-39.55x-7.20x
SCLX leads this category, winning 3 of 5 comparable metrics.

Total Returns (Dividends Reinvested)

PRGO leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in PRGO five years ago would be worth $3,986 today (with dividends reinvested), compared to $231 for SCLX. Over the past 12 months, SCLX leads with a +74.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors PRGO at -25.2% vs SCLX's -64.5% — a key indicator of consistent wealth creation.

MetricSCLX logoSCLXScilex Holding Co…PRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date-38.6%-13.5%
1-Year ReturnPast 12 months+74.4%-51.2%
3-Year ReturnCumulative with dividends-95.5%-58.1%
5-Year ReturnCumulative with dividends-97.7%-60.1%
10-Year ReturnCumulative with dividends-97.7%-77.7%
CAGR (3Y)Annualised 3-year return-64.5%-25.2%
PRGO leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

PRGO leads this category, winning 2 of 2 comparable metrics.

PRGO is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than SCLX's 2.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRGO currently trades 41.2% from its 52-week high vs SCLX's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSCLX logoSCLXScilex Holding Co…PRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5002.50x1.18x
52-Week HighHighest price in past year$34.27$28.44
52-Week LowLowest price in past year$3.92$9.23
% of 52W HighCurrent price vs 52-week peak+23.5%+41.2%
RSI (14)Momentum oscillator 0–10059.360.9
Avg Volume (50D)Average daily shares traded55K3.4M
PRGO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates SCLX as "Buy" and PRGO as "Hold". PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.

MetricSCLX logoSCLXScilex Holding Co…PRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$20.00
# AnalystsCovering analysts236
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises10
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

PRGO leads in 2 of 6 categories (Total Returns, Risk & Volatility). SCLX leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallPerrigo Company plc (PRGO)Leads 2 of 6 categories
Loading custom metrics...

SCLX vs PRGO: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is SCLX or PRGO a better buy right now?

For growth investors, Scilex Holding Company (SCLX) is the stronger pick with 21.

1% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Analysts rate Scilex Holding Company (SCLX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SCLX or PRGO?

Over the past 5 years, Perrigo Company plc (PRGO) delivered a total return of -60.

1%, compared to -97. 7% for Scilex Holding Company (SCLX). Over 10 years, the gap is even starker: PRGO returned -77. 7% versus SCLX's -97. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SCLX or PRGO?

By beta (market sensitivity over 5 years), Perrigo Company plc (PRGO) is the lower-risk stock at 1.

18β versus Scilex Holding Company's 2. 50β — meaning SCLX is approximately 112% more volatile than PRGO relative to the S&P 500.

04

Which is growing faster — SCLX or PRGO?

By revenue growth (latest reported year), Scilex Holding Company (SCLX) is pulling ahead at 21.

1% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Scilex Holding Company grew EPS 56. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, SCLX leads at 21. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SCLX or PRGO?

Perrigo Company plc (PRGO) is the more profitable company, earning -33.

5% net margin versus -128. 7% for Scilex Holding Company — meaning it keeps -33. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus -147. 4% for SCLX. At the gross margin level — before operating expenses — SCLX leads at 70. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is SCLX or PRGO more undervalued right now?

On forward earnings alone, Scilex Holding Company (SCLX) trades at 2.

6x forward P/E versus 5. 6x for Perrigo Company plc — 3. 0x cheaper on a one-year earnings basis.

07

Which pays a better dividend — SCLX or PRGO?

In this comparison, PRGO (9.

8% yield) pays a dividend. SCLX does not pay a meaningful dividend and should not be held primarily for income.

08

Is SCLX or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 8% yield). Scilex Holding Company (SCLX) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRGO: -77. 7%, SCLX: -97. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between SCLX and PRGO?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SCLX is a small-cap high-growth stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while SCLX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SCLX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 41%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SCLX and PRGO on the metrics below

Revenue Growth>
%
(SCLX: -26.8% · PRGO: -7.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.